A study found a reduction in the serum BAFF levels of SLE patients with no change in the SLEDAI-2K between visits; however, baseline serum BAFF and APRIL concentrations did not associate with subsequent changes in disease activity11. The gene discussed is TNFSF13B; the disease is systemic lupus erythematosus.